Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of anti-inflammatory and central nervous system agents. Its structure supports the design of compounds with enhanced metabolic stability and binding affinity due to the presence of the trifluoromethyl group. Commonly employed in medicinal chemistry for optimizing drug candidates targeting neurological disorders and chronic pain. Also utilized in the preparation of specialty organic molecules requiring fluorinated building blocks for improved pharmacokinetic properties.